Page last updated: 2024-08-21

perflexane and Cancer of Stomach

perflexane has been researched along with Cancer of Stomach in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ding, P; Huang, C; Li, M; Liu, H; Liu, Z; Xin, Y; Zhang, Y; Zhao, X; Zhou, H1
Liu, Z; Ran, H; Wang, Y; Wang, Z; Zhou, S1

Other Studies

2 other study(ies) available for perflexane and Cancer of Stomach

ArticleYear
"PFH/AGM-CBA/HSV-TK/LIPOSOME-Affibody": Novel Targeted Nano Ultrasound Contrast Agents for Ultrasound Imaging and Inhibited the Growth of ErbB2-Overexpressing Gastric Cancer Cells.
    Drug design, development and therapy, 2022, Volume: 16

    Topics: Antiviral Agents; Contrast Media; Fluorocarbons; Ganciclovir; Humans; Liposomes; Male; Receptor, ErbB-2; Simplexvirus; Stomach Neoplasms; Thymidine Kinase; Transfection; Ultrasonography

2022
Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect.
    International journal of nanomedicine, 2019, Volume: 14

    Topics: Animals; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Compounding; Drug Liberation; Female; Fluorocarbons; Humans; Hydrogen-Ion Concentration; Mice, Nude; Nanoparticles; Oligopeptides; Optical Imaging; Phase Transition; Polylactic Acid-Polyglycolic Acid Copolymer; Stomach Neoplasms; Theranostic Nanomedicine; Tissue Distribution; Ultrasonography

2019